Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Pyrosequencing Market Share, Size, Growth, Analysis, Forecast: By Application: Drug Discovery, Biomarker Discovery, Diagnostics, Personalised Medicine, Others; By End Use: Hospitals, Clinics, Research Centres and Academic Institutes, Others; Regional Analysis; Competitive Landscape; Industry Events and Developments; 2023-2028

Global Pyrosequencing Market Outlook

The global pyrosequencing market is expected to grow at a CAGR of 11.80% between 2023 and 2028.  Key market drivers are increased demand for DNA sequencing, reduced detection time, and applications in drug development and other fields. 

 

Key Trends in the Market

Pyrosequencing is a technique for DNA sequencing that is based upon sequencing-by-synthesis that facilitates the determination of real-time sequences at a faster rate. It is mainly used to identify the genetic code from a section of DNA. It has various advantages including flexibility, easy automation, accuracy, and parallel processing.

 

  • The increasing prevalence of chronic diseases are driving the demand for personalised medicines among patients for more effective and long-term results. Personalised medicines and treatments typically require accurate DNA sequencing for optimum results, ultimately leading to the growth of the market for pyrosequencing.
  • Pyrosequencing facilitates faster detection of DNA sequences which is why it is largely adopted by doctors and end users fuelling the growth of the pyrosequencing market. Faster decoding of DNA enables quicker treatment and responses, improving patient outcomes.
  • Investments by both the private sector and various governments for carrying out development and advancements in pyrosequencing technology has also contributed to the growth of the market.

 

Market Analysis

Based on application, the market can be divided into drug discovery, biomarker discovery, diagnostics, and personalised medicine, among others. On the basis of end use, the market is segmented into hospitals, clinics, research centres and academic institutes, and others. Based on region, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global pyrosequencing market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

 

  • QIAGEN
  • Biotage AB
  • EpigenDX
  • Lumitos AG
  • Others

 

Market Share by End Use

Hospitals and clinics are leading end-users for the pyrosequencing market as they directly treat patients and acquire samples of DNA for personalised medicine. With increase in chronic diseases such as cancer, hepatitis B, and liver diseases, and growing prevalence of infectious diseases, the shift towards personalised medicines is fuelling the growth of the market for pyrosequencing. 

 

In research centres, pyrosequencing is used for drug development, bacteria resistance screening, epigenetics, and various other processes required in the pharmaceutical and medical sector. As more manufacturers invest in advanced research and development activities, the end use applications of pyrosequencing in research centres and academic institutes is expected to increase in the coming years. 

 

Market Share by Region

North America accounts for a substantial share in the pyrosequencing market at a regional level because of the increasing adoption of advanced analytical and diagnostic tools. There is a greater level of awareness among patients and providers regarding personalised medicines ultimately increasing the use of pyrosequencing in North America region. 

 

The United States has advanced healthcare infrastructure, is quick to adopt new technologies, and has extensive investments in research and development, increasing the market size for North America in the forecast period as well. Europe and Asia Pacific have also observed significant growth in the market, fuelled by adoption of new treatments and technologies that utilise pyrosequencing. 

 

Competitive Landscape

QIAGEN is a German technology company that has its headquarter in Hilden, Germany. It was founded in 1984 and provides assay and sample technologies for use in applied testing, molecular diagnostics, and pharmaceutical and academic research. 

 

Biotage AB founded in 1969 is based out of Uppsala in Sweden. It is a life science company which develops technologies that help in various syntheses and separations. It provides solutions for peptide synthesis, medicinal and analytical chemistry, purification, separation, and chromatography. 

 

Lumitos AG was founded in 2000 and has its headquarter in Berlin, Germany. It is an online video and audio media company that provides assistance to various markets such as life science, food and beverage, chemical, pharmaceutical, analytical, and laboratories through online modes. 

 

Other market players include EpigenDX, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Application
  • End Use
  • Region
Breakup by Application
  • Drug Discovery
  • Biomarker Discovery
  • Diagnostics
  • Personalised Medicine
  • Others
Breakup by End Use
  • Hospitals
  • Clinics
  • Research Centres and Academic Institutes
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • QIAGEN
  • Biotage AB
  • EpigenDX
  • Lumitos AG
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Pyrosequencing Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Pyrosequencing Historical Market (2018-2022) 
    8.3    Global Pyrosequencing Market Forecast (2023-2028)
    8.4    Global Pyrosequencing Market by Application
        8.4.1    Drug Discovery
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Biomarker Discovery
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Diagnostics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Personalised Medicine
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
        8.4.5    Others
    8.5    Global Pyrosequencing Market by End Use
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Clinics
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Research Centres and Academic Institutes
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Others
    8.6    Global Pyrosequencing Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    QIAGEN
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Biotage AB
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    EpigenDX
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Lumitos AG
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Pyrosequencing Market: Key Industry Highlights, 2018 and 2028
2.    Global Pyrosequencing Historical Market: Breakup by Application (USD Million), 2018-2022
3.    Global Pyrosequencing Market Forecast: Breakup by Application (USD Million), 2023-2028
4.    Global Pyrosequencing Historical Market: Breakup by End Use (USD Million), 2018-2022
5.    Global Pyrosequencing Market Forecast: Breakup by End Use (USD Million), 2023-2028
6.    Global Pyrosequencing Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Pyrosequencing Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Pyrosequencing Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Pyrosequencing Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Pyrosequencing Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Pyrosequencing Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Pyrosequencing Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Pyrosequencing Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Pyrosequencing Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Pyrosequencing Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Pyrosequencing Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Pyrosequencing Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Pyrosequencing Market Structure

Key Questions Answered in the Report

The market is expected to grow at a CAGR of 11.80% between 2023 and 2028.

The major market drivers include applications in drug development and other fields, shorter sequencing times, and technological advancements.

The key trends of the market are rising prevalence of chronic diseases, growing popularity of personalised medicine, and investments from public and private sectors.

Key market players include QIAGEN, Biotage AB, EpigenDX, and Lumitos AG, among others.

Pyrosequencing is a technique for DNA sequencing that is based upon sequencing-by-synthesis that facilitates the determination of real-time sequencing at a faster rate.

It is mainly used to identify the genetic code from a section of DNA.

The global pyrosequencing market is segmented based on application, end use, and region.

Pyrosequencing has various advantages including flexibility, easy automation, accuracy, and parallel processing.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER